定量肿瘤异质性MRI分析改善转移性结肠癌患者基于机器学习的预后预测
本回顾性研究纳入55例伴肝转移的Ⅳ期结肠癌患者共94个肝转移灶,从增强MRI图像提取异质性纹理特征,用随机森林模型预测生存。加入影像异质性特征后模型AUC由0.83提升至0.94,提示MRI纹理特征与患者生存相关并补充临床病理变量。
要点
- MRI肿瘤异质性纹理特征与转移性结肠癌患者生存结局相关。
- 影像纹理特征可补充标准临床和病理变量用于预后预测。
- 加入影像特征后随机森林模型生存预测AUC由0.83升至0.94。
核心结论
- 基于MRI的纹理特征与患者结局相关,并改善标准临床和病理变量对转移性结直肠癌患者生存的预测性能。
研究设计与样本
- 经IRB批准的回顾性研究,纳入55例已知肝转移的Ⅳ期结肠癌患者,在增强MRI图像上识别并手动容积分割94个肝转移灶。
- 从每个病灶提取异质性表型向量,单变量回归分析评估110个提取特征对生存预测的贡献。
- 采用随机森林机器学习方法分析特征向量及标准预后临床和病理变量,数据集按4:1分为训练集和测试集,用ROC分析和混淆矩阵分析评估分类性能。
关键影像表现/征象
- 研究人群平均生存时间为39±3.9个月。
- 共22个纹理特征与患者生存相关(p<0.05)。
- 凝聚层次聚类显示患者生存结局与不同的MRI肿瘤轮廓相关。
诊断标准与关键数值
- 仅纳入标准临床和病理预后变量的随机森林模型ROC曲线下面积为0.83。
- 在临床和病理变量基础上加入影像异质性特征的模型生存预测性能改善,AUC为0.94。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Intra-tumor heterogeneity has been previously shown to be an independent predictor of patient survival. The goal of this study is to assess the role of quantitative MRI-based measures of intra-tumor heterogeneity as predictors of survival in patients with metastatic colorectal cancer.
METHODS: In this IRB-approved retrospective study, we identified 55 patients with stage 4 colon cancer with known hepatic metastasis on MRI. Ninety-four metastatic hepatic lesions were identified on post-contrast images and manually volumetrically segmented. A heterogeneity phenotype vector was extracted from each lesion. Univariate regression analysis was used to assess the contribution of 110 extracted features to survival prediction. A random forest-based machine learning technique was applied to the feature vector and to the standard prognostic clinical and pathologic variables. The dataset was divided into a training and test set at a ratio of 4:1. ROC analysis and confusion matrix analysis were used to assess classification performance.
RESULTS: Mean survival time was 39 ± 3.9 months for the study population. A total of 22 texture features were associated with patient survival (p < 0.05). The trained random forest machine learning model that included standard clinical and pathological prognostic variables resulted in an area under the ROC curve of 0.83. A model that adds imaging-based heterogeneity features to the clinical and pathological variables resulted in improved model performance for survival prediction with an AUC of 0.94.
CONCLUSIONS: MRI-based texture features are associated with patient outcomes and improve the performance of standard clinical and pathological variables for predicting patient survival in metastatic colorectal cancer.
KEY POINTS: • MRI-based tumor heterogeneity texture features are associated with patient survival outcomes. • MRI-based tumor texture features complement standard clinical and pathological variables for prognosis prediction in metastatic colorectal cancer. • Agglomerative hierarchical clustering shows that patient survival outcomes are associated with different MRI tumor profiles.
引用
- Daye D, Tabari A, Kim H, et al. Quantitative tumor heterogeneity MRI profiling improves machine learning-based prognostication in patients with metastatic colon cancer. Eur Radiol. 2021. PMID: 33454799. doi:10.1007/s00330-020-07673-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。